Global Oncology/Cancer Drugs Market is Booming. Watch Out Latest Trends and Issues!

Biological drugs based on monoclonal antibodies (mAbs) have emerged as a preferred option for treating various cancer types, especially for blood cancer (leukemia).

Rising incidence of various cancer conditions, growing popularity of advance therapies (biological and targeted drug therapies), patents expiration of leading drugs along with commercialization of biosimilars are the few factors driving the growth of global oncology drugs market.
Check complete report @
http://www.marketintelreports.com/report/allied0122/global-oncologycancer-drugs-market-therapeutic-modalities-cancer-types-and-geography--size-share-trends-company-profiles-demand-insights-analysis-research-report-opportunities-segmentation-and-forecast-2013--2020

However, high cost involved in new drug development coupled with threat of failure and adverse effects associated with cancer drugs therapies would restrain the growth of the market. Commercialization of advanced therapeutics such as targeted and immunotherapies would reduce the negative influence of restraints and fuel the market growth.The global oncology drugs market is expected to reach at $111.9 billion by 2020. Patent expiration of key cancer drugs such as Herceptin, Erbitux, Rituxan and Avastin, is expected to boost the growth of cancer biosimilars market by 2020. Going further, the biological therapies are expected to dominate the market by 2020, due to their high efficacy, target specific action and less toxicity. Blood cancer drugs market was the largest revenue generating segment in 2013 owing to the high cost of drugs (immunotherapies) used for the treatment of blood cancer.Geographically, North America, dominates the market followed by Europe.
North America accounted for about ~38% share in the overall oncology drugs market in 2013 owing to the heavy investments by multinational companies in research and development of cancer drugs, particularly immune therapeutics, favorable reimbursement policies, and high adoption rate of immunotherapies. On the other hand, Asia-Pacific market would grow at the promising CAGR of 8.7% during the forecast period.
Such high growth rate is majorly due to increasing awareness towards advanced therapies namely immunotherapies and increase in per capita healthcare spending.Key companies profiled in the report are Roche diagnostics, Novartis AG, Celgene Corporation, AstraZeneca, Johnson & Johnson, Merck & Co., Eli Lilly & Co. and GlaxoSmithKline. Companies operating in the cancer drugs market focus on several strategies such as collaboration, approval and acquisition.KEY BENEFITSThe report provides the quantitative analysis of the current market and estimations through 2013-2020 that assists in identifying the prevailing market opportunities to capitalize onThe report helps in understanding the strategies adopted by various companies for gaining market share in the cancer drugs marketThe report provides comprehensive analysis of factors that drive and restrict the growth of the cancer drugs marketMarket conditions of cancer drugs market across all geographic regions are comprehensively analyzedCompetitive intelligence (of leading manufacturers) helps in understanding the competitive scenario across the geographiesSWOT analysis of the key market players is provided to illustrate the business strategies adopted by the companiesMARKET SEGMENTATIONThe cancer drugs market is segmented by the therapeutic modalities, cancer types and geography.MARKET BY THERAPEUTIC MODALITIESChemotherapyTargeted TherapyImmunotherapy (Biologic Therapy)Hormonal TherapyOthersMARKET BY CANCER TYPESBlood CancerBreast CancerGastrointestinal CancerProstate CancerRespiratory/Lung CancerSkin CancerOther CancersMARKET BY GEOGRAPHYNorth AmericaUnited StatesCanadaMexicoEuropeGermanyFranceUnited KingdomOthersAsia-PacificIndiaChinaJapanAustraliaOthersLAMEAGCC (Gulf Corporation Council)Others

Order a copy of Report @ http://www.marketintelreports.com/purchase.php?id=allied0122


Contact Details

Company Name: marketintelreports
Issued By: hemanth
Phone: 1-302-261-5343
Address: delaware
City: Wilmington
State: Delaware
Zip: 19808
Country: United States
Website: Visit the website

Keywords : Oncology, Cancer Drugs, Market, research, analysis, strategy,

by hemanth (last year!)

Latest Press Releases

The Mad Hatter Now Offer a Full Line of Hearth Products and Full Line of Grills

Diabetes Insulin Delivery Pens Market Research Report 2018

Dr Kapadia Provides Tips to Patients Interested in Hair Transplant Procedures

love vashikaran specialist

Solar Blanket Sales Market Report 2018

Spring Bottled Water Market Insights, Forecast to 2025

Biochemical Incubator Sales Market Report 2018

Quinine Sulphate Sales Market Report 2018

Automotive Chassisc System Market Insights, Forecast to 2025

2,6-Dicarboxypyridine market size in key regions like North America, Europe, Asia Pacific an..

Remove this press release ?

Due to extra work required to remove the press-releases we have started charging $1.99 for press release removal.

Your press release will be removed in 24 hours, once the payment has been received.

Search Press Release
e.g. Business, Computer, etc.